Related Articles
Ezetimibe prevents the development of non‑alcoholic fatty liver disease induced by high‑fat diet in C57BL/6J mice
LRG ameliorates steatohepatitis by activating the AMPK/mTOR/SREBP1 signaling pathway in C57BL/6J mice fed a high‑fat diet
Efficacy of orlistat in non‑alcoholic fatty liver disease: A systematic review and meta‑analysis
Non‑alcoholic fatty liver disease: A major challenge in type 2 diabetes mellitus (Review)
Hepatic expression of the Sptlc3 subunit of serine palmitoyltransferase is associated with the development of hepatocellular carcinoma in a mouse model of nonalcoholic steatohepatitis